BR112017026003A2 - ?agente de imagem de diagnóstico para metástase óssea precoce de câncer? - Google Patents

?agente de imagem de diagnóstico para metástase óssea precoce de câncer?

Info

Publication number
BR112017026003A2
BR112017026003A2 BR112017026003A BR112017026003A BR112017026003A2 BR 112017026003 A2 BR112017026003 A2 BR 112017026003A2 BR 112017026003 A BR112017026003 A BR 112017026003A BR 112017026003 A BR112017026003 A BR 112017026003A BR 112017026003 A2 BR112017026003 A2 BR 112017026003A2
Authority
BR
Brazil
Prior art keywords
cancer
imaging agent
diagnostic imaging
bone metastasis
early bone
Prior art date
Application number
BR112017026003A
Other languages
English (en)
Inventor
Otaka Akiharu
Teramachi Masako
Kanagawa Masaru
Watanabe Satoshi
Oka Shuntaro
Nagatomo Toshie
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of BR112017026003A2 publication Critical patent/BR112017026003A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

é fornecido um agente de imagem de diagnóstico para metástase de osso cedo a partir de câncer, contendo trans-1-amino-[18f] fluorociclobutanocarboxílico ácido ou um sal farmaceuticamente aceitável do mesmo como ingrediente ativo.
BR112017026003A 2015-06-04 2016-06-01 ?agente de imagem de diagnóstico para metástase óssea precoce de câncer? BR112017026003A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015113587 2015-06-04
PCT/JP2016/002654 WO2016194372A1 (en) 2015-06-04 2016-06-01 Diagnostic imaging agent for early bone metastasis from cancer

Publications (1)

Publication Number Publication Date
BR112017026003A2 true BR112017026003A2 (pt) 2018-08-14

Family

ID=57442325

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017026003A BR112017026003A2 (pt) 2015-06-04 2016-06-01 ?agente de imagem de diagnóstico para metástase óssea precoce de câncer?

Country Status (11)

Country Link
US (1) US10857245B2 (pt)
EP (1) EP3302581B1 (pt)
JP (1) JP6789991B2 (pt)
KR (1) KR102599293B1 (pt)
CN (1) CN107847616B (pt)
AU (1) AU2016271942B2 (pt)
BR (1) BR112017026003A2 (pt)
CA (1) CA2987372C (pt)
HK (1) HK1246647A1 (pt)
TW (1) TWI734688B (pt)
WO (1) WO2016194372A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170108822A (ko) * 2016-03-18 2017-09-27 니혼 메디피직스 가부시키가이샤 조골형 골전이 모델 동물의 제조 방법
CN108586524B (zh) * 2018-05-28 2019-10-01 厦门大学 氟代氧化膦类化合物及其在正电子发射显像中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632486B1 (en) * 1998-08-21 2009-12-15 Etsuro Ogata Method for diagnosing bone metastasis of malignant tumor
JP4397540B2 (ja) * 2001-03-16 2010-01-13 日本メジフィジックス株式会社 癌の骨転移治療法選択のための画像診断用薬剤
US8652469B2 (en) 2005-07-28 2014-02-18 Novartis Ag M-CSF-specific monoclonal antibody and uses thereof
KR101608755B1 (ko) * 2005-11-29 2016-04-04 니혼 메디피직스 가부시키가이샤 방사성 할로겐 표식 유기 화합물의 전구체 화합물
US20100032575A1 (en) * 2008-08-08 2010-02-11 Andrei Iagaru Methods and systems for pet/ct scanning for evaluation of malignancy
US20120010601A1 (en) * 2010-07-09 2012-01-12 Vanderbilt University Orthopedic cement and use of same in radiation therapy

Also Published As

Publication number Publication date
EP3302581A4 (en) 2019-01-09
JP6789991B2 (ja) 2020-11-25
US10857245B2 (en) 2020-12-08
KR20180015154A (ko) 2018-02-12
AU2016271942A1 (en) 2017-12-07
KR102599293B1 (ko) 2023-11-07
EP3302581A1 (en) 2018-04-11
CN107847616A (zh) 2018-03-27
CA2987372A1 (en) 2016-12-08
TW201642910A (zh) 2016-12-16
HK1246647A1 (zh) 2018-09-14
WO2016194372A1 (en) 2016-12-08
EP3302581B1 (en) 2021-04-28
CA2987372C (en) 2024-02-20
US20180161463A1 (en) 2018-06-14
AU2016271942B2 (en) 2021-07-15
JP2018516941A (ja) 2018-06-28
CN107847616B (zh) 2021-05-07
TWI734688B (zh) 2021-08-01

Similar Documents

Publication Publication Date Title
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201690372A1 (ru) Азапиридоновые соединения и их применение
EA201692436A1 (ru) Медицинское применение
CL2015002122A1 (es) Moduladores de receptores nmda de espiro-lactama y sus usos.
HK1252661A1 (zh) 離體器官護理系統用的主動脈插管
MD4684B1 (ro) Formulări pe bază de imidazopirazine în calitate de inhibitori SYK
MX2015011913A (es) Moduladores de acido oxabiciclo[2.2.2] gpr120.
CL2015002027A1 (es) Compuestos quimicos
BR112014028042A2 (pt) inibidores de nampt
EA201692003A1 (ru) Макроциклические производные пиримидина
EA201690371A1 (ru) Пиридазиноновые соединения и их применение
BR112015010791A2 (pt) moduladores de gpr40 de di-hidropirazol
PH12017500533A1 (en) 1-alkyl-6-oxo-1, 6-dihydropyridin-3-yl compounds and use as sgrm modulators
BR112016017317A8 (pt) composto, antagonista de trpa1, medicamento, e, método para profilaxia e/ou tratamento de uma doença que envolve trpa1
GT201700280A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
MX362919B (es) Moduladores del receptor acoplado a proteína-g 120 (gpr120) de ácido biciclo-[2.2.1].
CL2015003563A1 (es) Marcador para trastornos de la esfingomielinasa ácida y sus usos.
EP3402537A4 (en) QUANTITATIVE PET IMAGING OF TISSUE FACTOR EXPRESSION EMPLOYING INHIBITED FACTOR VII AT ACTIVE SITE MARKETED AT 18F
BR112017026003A2 (pt) ?agente de imagem de diagnóstico para metástase óssea precoce de câncer?
EA201890896A1 (ru) Твердый препарат для перорального применения, содержащий аморфный солифенацин, и способ его получения
MX2018002859A (es) Extracto de gardenia para colorear la piel.
EA201270176A1 (ru) Производные тазаротена
MX2018000336A (es) Fluido terapeutico peritoneal.
IN2013MU03118A (pt)

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]